Press Releases on November 9, 2024 - EIN Presswire - Press Release Distribution Service

Published on November 9, 2024 - 23:27 GMT

Match Group, Inc. Announcement: If You Have Suffered Losses Match Group, Inc. (NASDAQ: MTCH), You Are Encouraged to Contact The ...

NEW YORK, Nov. 09, 2024 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Match Group, Inc. (NASDAQ: MTCH) resulting from allegations that …

Distribution channels:

Published on November 9, 2024 - 23:26 GMT

PACS Group, Inc. ANNOUNCEMENT: If You Have Suffered Losses in PACS Group, Inc. (NYSE: PACS), You Are Encouraged to Contact The ...

NEW YORK, Nov. 09, 2024 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of PACS Group, Inc. (NYSE: PACS) resulting from allegations that PACS …

Distribution channels:

Published on November 9, 2024 - 23:16 GMT

Brazil and Sweden deepen aerospace cooperation

SWEDEN, November 9 - Press release from Ministry of Defence Published 09 November 2024 Brazil is planning to extend the contract on Jas 39 Gripen fighter aircraft from Sweden, while Sweden is ready to begin negotiations to purchase Embraer C-390 transport …

Distribution channels:

Published on November 9, 2024 - 22:54 GMT

Ships Set Sail for Phase Two of Exercise Phoenix Express 2024

This marks the commencement of the at-sea phase for Phoenix Express 24. PE24 is a multinational maritime exercise held in the Mediterranean Sea. This phase evaluates the capacity of participating vessels and maritime operation centers (MOC) to carry out …

Distribution channels: Military Industry

Published on November 9, 2024 - 22:29 GMT

ALK indlicenserer rettigheder til neffy®, den første godkendte næsespray med adrenalin til akut behandling af allergiske ...

ALK (ALKB:DC / OMX: ALK B) har i dag annonceret, at selskabet har indgået en strategisk licensaftale med USA-baserede ARS Pharmaceuticals, Inc. (”ARS Pharma”) (NASDAQ: SPRY). Aftalen giver ALK eksklusive rettigheder til neffy® adrenalin-næsesprayen globalt …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on November 9, 2024 - 22:29 GMT

ALK licenses rights to neffy®, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (...

ALK (ALKB:DC / OMX: ALK B) today announced that it has entered into a strategic license agreement with US-based ARS Pharmaceuticals, Inc. (“ARS Pharma”, NASDAQ: SPRY). The agreement grants ALK exclusive global rights to the neffy® adrenaline (epinephrine) …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on November 9, 2024 - 22:21 GMT

MGX DEADLINE NOTICE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Metagenomi, Inc. Investors with Losses in Excess of $100K to ...

NEW YORK, Nov. 09, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of Metagenomi, Inc. (NASDAQ: MGX) pursuant and/or traceable to the Company’s initial public offering conducted between February …

Distribution channels: Consumer Goods, Law ...